Abstract
The study was intended to evaluate the impact of closure devices on vascular complication and mortality in transfemoral aortic valve implantation (TAVI TF). Between 2009 and 2014, 398 patients (pts.) underwent TAVI TF using two different closure devices, Prostar XL (n=215) and Perclose-Proglide (n=
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.